Data Sharing, Intellectual Property, and Publication policy
|
|  Yüklə 62.5 Kb.
|
D ata Sharing, Intellectual Property, and Publication policy
Previous version approved by the MIDAS Steering Committee January 17, 2006 MIDAS (Models of Infectious Disease Agent Study) creates computational models that will be useful to policymakers, public health professionals, and the research community. In order to maximize the utility and distribution of information and technology, MIDAS has developed policies to
The Research Groups and Information Technology Resource will work proactively to address issues relating to data and material sharing and intellectual property. D  ATA SHARING
Consistent with NIH policy, all data supporting work on MIDAS research projects should be shared with the research community, while safeguarding the privacy of participants, and protecting confidential and proprietary data. Use of the latter data should be minimal, and only when essential to pursue critical research and policy objectives. It is especially important to share unique data that is otherwise not readily available. The policies for information and material sharing apply to all MIDAS research and resource activities conducted by funded Research Groups and the Information Technology Resource. MIDAS investigators will deposit annotated data sets to the MIDAS Portal, recognizing the importance of timeliness, annotation, and completeness. Consistent with NIH policy, data should be deposited no later than the date of acceptance for publication of the main findings from the data. Except in the case of an emergency, it will be a MIDAS community standard that the MIDAS research group which first obtained the data will be afforded sufficient time to analyze the set before other MIDAS groups conduct analyses of that set. It is also a MIDAS standard for scientific authors to acknowledge the source of data on which manuscripts and presentations are based. MIDAS uses existing or simulated data. Because of the importance of maintaining reference and master data sets, all data sets used as the basis of MIDAS research will be deposited in the Data Repository maintained by the MIDAS Information Technology Resource. Publicly-Available Data Much data (e.g., non-human, non-sensitive data, aggregated data) can be made broadly available and will be submitted to the ITR concurrently with publication or public presentation of analyses or models based on the data. Once collected, data will be put into computable form and will become available to MIDAS researchers on the MIDAS Portal through use of an access code. Data will become available to the public within 6 months of being released to MIDAS investigators. Intellectual Property Institutional reviews of data related to intellectual property, if any, must be conducted within the 6 month window. Confidential Data MIDAS may receive data that are critical to the program’s mission and that must be confidential. Data providers may entrust MIDAS researchers with confidential information needed to address certain public health issues. Such information can be restricted to MIDAS-funded investigators and shared only on a need-to-know basis and with the concurrence of the data provider. Data will be maintained with appropriate levels of security by the ITR. Human Subjects Issues Use of human subjects data is subject to the policies of NIH and grantee institutions. MIDAS investigators should check with their Institutional Review Boards if they plan to acquire or use information derived from human subjects or material. Researchers who seek access to individual level data may be required to enter into a data-sharing agreement or confidential data agreements, which would typically include requirements to protect participants' privacy and data confidentiality. The procedures adopted to share data while protecting privacy should be individually tailored to the specific dataset. PUBLICATION AND PRESENTATION POLICY
All MIDAS publications will be made available to the public through the MIDAS Portal and the NIGMS MIDAS web site. MIDAS-funded investigators will send copies of or links to publications as soon as they are published. MIDAS presentations are archived by the ITR on the MIDAS Portal. Presentations made at a MIDAS meeting or in any capacity as a MIDAS researcher must be archived on the Portal. MODEL SHARING MIDAS will achieve its goals most rapidly if there is extensive collaboration to test and verify models, compare model performance, and statistically analyze MIDAS outcomes.
Detailed descriptions of MIDAS analytic and simulation software will be made available to all MIDAS investigators through the secure MIDAS website. Each Research Group is responsible for regularly updating and documenting these descriptions. Access to analytic and simulation software that can be of public use should be made available on the MIDAS Portal. INTELLECTUAL PROPERTY CONSIDERATIONS Inventions. Working within the timing constraints of placing program information into the public domain, member institutions may seek intellectual property protection for technology and data obtained in this project. Participating Investigators who file invention disclosures which result from collaborative research are expected to disclose the collaborative nature of the research and the names of the other participating investigators and their institutions. Inventorship will be determined by U.S. Law. Title to inventions will be determined by the inventor's obligation to assign rights to his or her employers. In accordance with 37CFR401, no member institution shall assign its rights to any third party. Research license. Each member institution will grant to participating institutions and any other not-for-profit institution a non-exclusive, non royalty bearing, non-transferable license for purposes of non-commercial research, to all intellectual property developed in performance of this program. Title holders to intellectual property will be encouraged to license their intellectual property rights, when appropriate, and in compliance with the NIH guidelines, to non-participating third parties for purposes of developing commercial products and public benefit. Resolution of disputes. All disputes between participating institutions involving intellectual property will be resolved by alternative dispute resolution. The arbitrators shall be mutually agreed upon by the parties involved in the dispute. Disputes between participating institutions and NIGMS on scientific or program matters will be resolved by arbitration as described in the Request for Applications (http://grants.nih.gov/grants/guide/rfa-files/RFA-GM-01-004.html). USER AGREEMENT TO COMPLY WITH MIDAS INFORMATION POLICY MIDAS (Models of Infectious Disease Agent Study) creates computational models of emerging infectious diseases that will be useful to policymakers, public health professionals, and the research community. All users of MIDAS data, information, software, or technology (i.e., retrieved from the MIDAS Portal) agree to the following:
11/12/2009 |